
Role of edaravone in managemant of septic peritonitis
Author(s) -
Ghada Fouad Elbaradey,
Nagat S. Elshmaa,
Hossam Hodeib
Publication year - 2016
Publication title -
journal of anaesthesiology-clinical pharmacology/journal of anaesthesiology clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.466
H-Index - 32
eISSN - 2231-2730
pISSN - 0970-9185
DOI - 10.4103/0970-9185.194770
Subject(s) - medicine , edaravone , peritonitis , intensive care medicine , anesthesia
Sepsis is a complex rapidly progressive infectious disease that remain a major cause of morbidity and mortality in surgical patients and trauma victims. Edaravone a novel free radical scavenger was approved in 2001 in Japan for treatment of acute cerebral and myocardial infarction. Hence, in this work we attempt to evaluate its role in cases of septic peritonitis (SP).